BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18434359)

  • 1. A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis.
    Bujalska IJ; Gathercole LL; Tomlinson JW; Darimont C; Ermolieff J; Fanjul AN; Rejto PA; Stewart PM
    J Endocrinol; 2008 May; 197(2):297-307. PubMed ID: 18434359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake.
    McNelis JC; Manolopoulos KN; Gathercole LL; Bujalska IJ; Stewart PM; Tomlinson JW; Arlt W
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1134-44. PubMed ID: 24022868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
    De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
    Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
    Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
    J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children.
    Wang J; Sun B; Hou M; Pan X; Li X
    Int J Obes (Lond); 2013 Jul; 37(7):999-1005. PubMed ID: 23090578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
    Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol.
    Bujalska IJ; Walker EA; Tomlinson JW; Hewison M; Stewart PM
    Endocr Res; 2002 Nov; 28(4):449-61. PubMed ID: 12530648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis.
    Liu Y; Park F; Pietrusz JL; Jia G; Singh RJ; Netzel BC; Liang M
    Physiol Genomics; 2008 Feb; 32(3):343-51. PubMed ID: 18073273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat.
    Bujalska IJ; Durrani OM; Abbott J; Onyimba CU; Khosla P; Moosavi AH; Reuser TT; Stewart PM; Tomlinson JW; Walker EA; Rauz S
    J Endocrinol; 2007 Feb; 192(2):279-88. PubMed ID: 17283228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
    Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
    Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rise in expression and activity of 11β-HSD1 in human mesenchymal progenitor cells induces adipogenesis through increased local cortisol synthesis.
    Blaschke M; Koepp R; Streit F; Beismann J; Manthey G; Seitz MT; Kragl A; Siggelkow H
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105850. PubMed ID: 33639236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitor of 11-β hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells.
    Chang LL; Wun WA; Wang PS
    BMC Pharmacol Toxicol; 2018 Jul; 19(1):45. PubMed ID: 30021644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11beta-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates.
    Morita J; Hakuno F; Hizuka N; Takahashi S; Takano K
    Endocr J; 2009; 56(4):561-70. PubMed ID: 19352050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel 11β-HSD1 inhibitor from a high-throughput screen of natural product extracts.
    Park SB; Park JS; Jung WH; Park A; Jo SR; Kim HY; Dal Rhee S; Ryu SY; Jeong HG; Park S; Lee H; Kim KY
    Pharmacol Res; 2015 Dec; 102():245-53. PubMed ID: 26515507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
    Onyimba CU; Vijapurapu N; Curnow SJ; Khosla P; Stewart PM; Murray PI; Walker EA; Rauz S
    J Endocrinol; 2006 Aug; 190(2):483-93. PubMed ID: 16899581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels.
    Kim J; Temple KA; Jones SA; Meredith KN; Basko JL; Brady MJ
    J Biol Chem; 2007 Apr; 282(15):11038-46. PubMed ID: 17311922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.